The findings are limited to the 50 most-prescribed non-epilepsy drugs assessed in this Medicare population and may not generalize to non-Medicare beneficiaries who receive other non-epilepsy drugs.
Cannabinoids are effective as an adjunctive treatment for reducing seizure frequency in pediatric-onset treatment-resistant epilepsy.
Investigators sought to validate a tool to identify post-stroke seizure risk.
Participants in the progressive muscle relaxation group reported greater reductions in stress vs those randomized to the focused-attention activity.
Five studies demonstrated a significant improvement in serum 25-hydroxyvitamin D from baseline to post-treatment vitamin D supplementation in patients with epilepsy.
The study findings are particularly relevant given the current mismatch between clinical practice and regulatory approval of levetiracetam in infantile seizures.
The investigators hope that the consensus statement helps resolve several clinical questions in cases of pediatric new onset status epilepticus syndromes.
School performance is lower in children with prenatal exposure to valproate.
Participants recorded daily mood and stress ratings plus seizure counts using an electronic diary and medication adjustments were not allowed.
No increased risk of incident epilepsy was seen among children who received influenza vaccination during the 2009-2010 influenza season in Norway.
While epilepsy-related head trauma was common, 9 of 10 patients displayed no evidence of CTE.
The FDA has cleared the Embrace smart watch for managing epilepsy.
Add-on cannabidiol is associated with reduced monthy drop seizure frequency in patients with Lennox-Gastaut sydrome associated drop seizures.
Clinicians should evaluate their patients, especially patients with focal epilepsy, for mood disorders.
Women receiving topiramate for epilepsy were exposed to high cumulative doses, increasing the risk for oral clefts in offspring.
Patients with tough-to-treat seizures may require nonpharmacologic treatment such as resective surgery.
Over one-third of patients with newly diagnosed epilepsy do not respond to antiepileptic drug treatment.
Vitamin B6 was found to effectively treat the behavioral adverse effects seen with levetiracetam.
Research has found that gabapentin and pregabalin induced myoclonus is often seen but is rarely documented.
Children who are exposed to AEDs in utero may have a reduced risk of autistic traits.
Lamotrigine and levetiracetam are just as effective as other AEDs, and are better tolerated as well.
The FDA has accepted for filing with Priority Review the NDA for cannabidiol as seizure treatment.
The findings emphasize the importance of seizure control before pregnancy in women with epilepsy.
Stimulation of the other brain structures resulted in no significant blood pressure changes among the studied participants.
In patients with severe refractory focal epilepsy, add-on treatment with perampanel may be beneficial.
The findings further the utility of cerebral oximetry as a neurological assessment tool.
ZX008 has received Orphan Drug designation and Fast Track designation by the FDA for the treatment of Dravet syndrome.
Researchers from the University of Colorado reported on whether or not maternal antibiotic use during labor increased the risk of seizure for the neonate.
Treatment with enzalutamide for metastatic castration-resistant prostate cancer patients is not linked with increased seizure incidence.
Vigabatrin may be an effective option for patients with seizures due to tuberous sclerosis who do not respond to other anti-seizure treatments.
Neurology Advisor Articles
- Clarifying Cardiovascular Risk in Migraine
- Parkinson Disease Symptom Fluctuations Well-Managed With Adaptive Deep Brain Stimulation
- More Evidence Supports Benefits of Cannabidiol for Treatment-Resistant Epilepsy
- Monthly Erenumab Reduces Frequency of Episodic Migraine
- Reduced Risk for Multiple Sclerosis Linked to Greater Sun Exposure
- Tamsulosin Associated With Dementia Risk in Older Patients With BPH
- FDA Approves Blood Test to Assess Concussion
- Gait Difficulty in Parkinson Disease May Be Associated With More Progressive Disease Course
- Tau PET a Useful Biomarker for Alzheimer Disease Risk and Progression
- Multiple Sclerosis Drug Zinbryta Withdrawn From the Market
- Incidence of Delayed Traumatic Intracranial Hemorrhage Low in Older Adults With Blunt Head Trauma
- Older Epilepsy Patients More Likely to Experience AED, Non-AED Drug Interaction
- Female Gender, Natalizumab Exposure Associated With Increased Lymphopenia Risk in FNG-Treated MS
- Accelerated Cognitive Decline Associated With Retinopathy
- Treatment Effects Often Exaggerated in Early Clinical Studies